Showing 371-380 of 6630 results for "".
Allergan Board Rejects Latest Valeant Bid; Topical Jublia Approved for Onychomycosis
https://practicaldermatology.com/series/dermwire-tv/dwtv-6-12/19122/Allergan's board rejects the latest merger proposal from Valeant and the FDA approves topical Jublia for onychomycosis. LEarn about these developments and hear from the AMA's new president in this edition of DermWireTV.My Lumixyl Experience
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/my-lumixyl-experience/19444/A patient of Dr. Ashish Bhatia's, describes her experience using Lumixyl Brightening System for her adult acne.ASDS: Dr. Farah on Hair Loss Treatment Options
https://practicaldermatology.com/conferences/asds-2024-annual-meeting/asds-dr-farah-hair-regrowth-options/29152/Ronda Farah, MD, discusses treatment options for hair loss, including platelet-rich plasma and lasers, at the 2024 American Society for Dermatologic Surgery Annual Meeting.SCALE 2024: Dr. Michelle Henry on Innovative Skincare Products and Lasers in Skin of Color
https://practicaldermatology.com/conferences/scale-2024/scale-2024-dr-michelle-henry-innovative-skincare-products-and-lasers-skin-color/26374/Michelle Henry, MD, discusses innovative skincare products and lasers in skin of color, including her top 10 tips for ensuring best outcomes and reducing adverse events, at Music City SCALE.DermWireTV: Cosmetic Surgery Forum Highlights, LEO Focuses on AD
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-cosmetic-surgery-forum-highlights-leo-focuses-on-ad/19703/New treatments and medical controversies take center stage at Cosmetic Surgery Forum as the meeting moves to Nashville in its 11th Year. Leo Pharma’s tralokinumab meets all primary and secondary endpoints in three pivotal Phase 3 studies for the treatment of adults with moderate-to-severe atopic derThe New Vbeam Prima: One Laser System with Endless Potential
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/syneron-v-beam-webinar/19600/Join Gilly Munavalli, MD as he presents an overview of Candela’s newly introduced and powerful Vbeam Prima laser platform and shares his personal experience and successes with the system. Dr. Munavalli will discuss the benefits of the Vbeam Prima’s dual wavelengths and dual cooling options to treatTaltz Approved, Venus Versa Cleared, Sunbathing Linked to Longevity
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-taltz-approved-venus-versa-cleared-sunbathing-linked-to-longevity/18788/The IL-17 inhibitor Taltz (ixekizumab) from Eli Lilly is approved for adults with plaque psoriasis. Venus Concepts' Venus Versa is cleared for multiple aesthetic indications. Strata Sciences gets FDA clearance for new "Classifier Code" for use with MelaFind. Vitals.com shows that wait times are goinAchieving Optimal Outcomes with Laser Surgery
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/achieving-optimal-outcomes-with-laser-surgery/18818/Eric Bernstein, MD discusses a variety of laser and light devices and their benefits in treating a myriad of dermatological conditions as well as for cosmetic concerns. He also shares tips for how to use the devices safely to ensure optimal outcomes and to avoid adverse events.An Off-Label Adjuvant Treatment for Melanoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermtube-journal-club-alam-part-2/18642/In part two of DermTube Journal Club Host Dr. Joshua Zeichner's interview with Murad Alam, MD, they talk about the role of imiquimod as an adjuvant therapy in treating melanoma. Dr. Alam describes how he uses imiquimod off-label after removing melanoma to help prevent recurrence. He also shares howOff-label Uses for Biologics
https://practicaldermatology.com/topics/psoriasis/off-label-uses-for-biologics/18964/Derm Insider Bonus Content: Host Neal Bhatia speaks with guests Alice Gottlieb, MD, Harold Farber, MD, and James Ulery, MD about various potential off-label uses for current and investigational systemic psoriasis therapies.